Proinflammatory cytokine profiles of patients with elderly-onset rheumatoid arthritis: A comparison with younger-onset disease

Gerontology

Volumn 55, Issue 3, 2009, Pages 250-258

  Chen, Der Yuan ^a,c,f   Hsieh, Tsu Yi ^a,c,f   Chen, Yi Ming ^a,b,d,f   Hsieh, Chia Wie ^a,b,d   Lan, Joung Liang ^a,b,c,f,g   Lin, Fang Ju ^a,b,e  

^a Division of Immunology and Rheumatology

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c Chung Hsing University

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e HUNGKUANG UNIVERSITY   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Anti cyclic citrullinated peptide antibodies; Elderly onset rheumatoid arthritis; Proinflammatory cytokines; Rheumatoid factor; Younger onset rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN M; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PEPTIDE ANTIBODY; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; COMORBIDITY; CONTROLLED STUDY; CYTOMETRY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEPHELOMETRY; ONSET AGE; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SYMPTOM;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CITRULLINE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIDES, CYCLIC; RHEUMATOID FACTOR; TREATMENT OUTCOME;

EID: 67249147791     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000164393     Document Type: Article

References (53)

1. Brown JW, Sones DA: The onset of rheumatoid arthritis in the aged. J Am Geriatr Soc 1967; 10:873-881.
2. Ehrlich GE, Katz WA, Cohen SA: Rheumatoid arthritis in the aged. Geriatrics 1970; 25: 103-113.
3. Terkeltaub R, Esdaile J, Decary F, Tann-enbaum H: A clinical study of older age rheumatoid arthritis with comparison to a younger onset group. J Rheumatol 1983; 10: 418-424.
4. Ferraccioli GF, Cavalieri F, Mercandati M, Conti G, Viviano P, Ambanelli U: Clinical features, scintiscan characteristics and X-ray progression of late onset rheumatoid arthritis. Clin Exp R heumatol 1984; 2: 157-161.
5. Deal CL, Meenan RF, Goldenberg DL, Anderson JJ, Sack B, Pastan RS, Cohen AS: The clinical features of elderly-onset rheumatoid arthritis. Arthritis Rheum 1985; 28:987-994.
6. Inoue K, Shichikawa K, Nishioka J, Hirota S: Older age onset rheumatoid arthritis with or without osteoarthritis. Ann Rheum Dis 1987; 46: 908-911.
7. Van der Heijde DMFM, Van Riel PLCM, van Leeuwen MA, van Hof MA, van Rijswijk MH, van de Putte LBA: Older versus younger onset rheumatoid arthritis: results at onset and after 2 years of prospective follow-up study of early rheumatoid arthritis. J Rheumatol 1991; 18:1285-1289.
8. Van Schaardenburg D, Breedveld FC: Elderly-onset rheumatoid arthritis. Semin Arthritis R heum 1994; 23: 367-378.
9. Yacizi Y, Paget S: Elderly-onset rheumatoid arthritis. Rheum Dis Clin North Am 2000; 26: 517-526.
10. Hellier JP, Eliaou JF, Daurés JP, Sany J, Combe B: HLA-DRB1 genes and patients with late onset rheumatoid arthritis. Ann R heum Dis 2001; 60: 531-533.
11. Yukioka M, Wakitani S, Murata N, Toda Y, Ogawa R, Kaneshiga T, Ochi T: Elderly onset rheumatoid arthritis and its association with HLA-DRB1 alleles in Japanese. Br J Rheuma-tol 1998; 37:98-101.
12. Spector TD, Perry LA, Tubb G, Silman AJ, Huskisson EC: Low free testosterone levels in rheumatoid arthritis. Ann Rheum Dis 1988; 47: 65-68.
13. Wade AW, Green-Johnson J, Szewczuk MR: Functional changes in systemic and mucosal ly mphocy te repertoires with age: an updated review. Aging Immunol Infect Dis 1998; 1: 65-70.
14. Cutolo M, Montecucco CM, Cavagna L, Caporali R, Capellino S, Montagna P, Fazzuoli L, Villaggio B, Seriolo B, Sulli A: Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis. Ann Rheum Dis 2006; 65: 1438-1443.
15. Brennan FM, Maini RN, Feldmann M: Role of proinflammatory cytokines in rheumatoid arthritis. Springer Semin Immunopathol 1998; 20:133-147.
16. Christodoulou C, Choy EH: Joint inflammation and cytokine inhibition in rheumatoid arthritis. Clin Exp Med 2006; 6:13-19.
17. Lader CS, Flanagan AM: Prostaglandin E 2, interleukin-1 alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro. Endocrinology 1998; 139:3157-3164.
18. Kay J, Calabrese L: The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatology 2004; 43(suppl 3):iii2-iii9.
19. Neidel J, Schulze M, Lindschau J: Association between degree of bone erosion and synovial fluid levels of tumor necrosis factor-α in the knee joints of patients with rheumatoid arthritis. Inflamm Res 1995; 44:217-221.
20. Hirano T, Akira S, Taga T, Kishimoto T: Biological and clinical aspects of interleukin 6. Immunol Today 1990; 11:443-449.
21. Ishihara K, Hirano T: IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 2002; 13: 357-368.
22. Canete JD, Martinez SE, Farres J, Sanmarti R, Blay M, Gomez A, Salvador G, Munoz-Gomez J: Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon-7 is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies. Ann Rheum Dis 2000; 59: 263-268.
23. van Roon JA, van Roy JL, Duits A, Lafeber FP, Bijlsma JW: Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4. Ann Rheum Dis 1995; 54:836-840.
24. Koch AE, Volin MV, Woods JM, Kunkel SL, Connors MA, Harlow LA, Woodruff DC, Burdick MD, Strieter RM: Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint. Arthritis Rheum 2001; 44:31-40.
25. Caporali R, Montecucco C, Epis O, Bobbio-Pallavicini F, Maio T, Cimmino MA: Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: a prospective study. Ann Rheum Dis 2001; 60:1021-1024.
26. Healey LA: Polymyalgia rheumatica and seronegative rheumatoid arthritis may be the same entity. J Rheumatol 1992; 19:270-272.
27. Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R: Diagnostic accuracy of the anticitrulline antibody assay for rheumatoid arthritis. Clin Chem 2001; 47: 1089-1093.
28. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van-Venrooij WJ: Antibodies against citrullinated peptides (CCP) and immunoglobulin-A rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48:2741-2749.
29. Lopez-Hoyos M, de Allegria CR, Blanco R, Crespo J, Pena M, Rodriguez-Valverde V, Martinez-Taboada VM: Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica. Rheumatology 2004; 43: 655-657.
30. Arnett FC, Edworthy SM, Bloch DA, Mc-Shane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
31. Prevoo MLL, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LBA, van Riel PLCM: Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38:44-48.
32. Bird HA, Leeb BF, Montecucco CM, Misiuniene N, Nesher G, Pai S, Pease C, Rovensky J, Rozman B: A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica. Ann Rheum Dis 2005; 64: 626-629.
33. Plant MJ, Saklatvala J, Borg AA, Jones PW, Dawes PT: Measurement and prediction of radiographical progression in early rheumatoid arthritis. J Rheumatol 1994; 21:1808-1813.
34. Bajocchi G, La Corte R, Locaputo A, Govoni M, Trotta F: Elderly onset rheumatoid arthritis: clinical aspects. Clin Exp Rheumatol 2000; 18:S49-S50.
35. Sulli A, Montecucco CM, Caporali R, Cavagna L, Montagna P, Capellino S, Fazzuoli L, Seriolo B, Alessandro C, Secchi ME, Cutolo M: Glucocorticoid effects on adrenal steroids and cytokine responsiveness in polymyalgia rheumatica and elderly onset rheumatoid arthritis. Ann NY Acad Sci 2006; 1069:307-314.
36. Zwerina J, Redlich K, Polzer K, Joosten L, Kronke G, Distler J, Hess A, Pundt N, Pap T, Hoffmann O, Gasser J, Scheinecker C, Smolen JS, van den Berg W, Schett G: TNF-in-duced structural joint damage is mediated by IL-1. Proc Natl Acad Sci USA 2007; 104: 11742-11747.
37. Fleischmann RM, Schechtman J, Bennett R Handle ML, Burmester GR, Tesser J, Modafferi D, Poulakos J, Sun G: Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: a large, international, multicenter, placebo-controlled trial. Arthritis Rheum 2003; 48:927-934.
38. Fleischmann R, Iqbal I: Risk: benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis. Drugs Aging 2007; 24: 239-254.
39. Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, Harriman GR, Maini RN: Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000; 343:1594-1602.
40. Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, Birbara CA, Teoh LA, Fischkoff SA, Chartash EK: Adalimu-mab, a fully human anti-tumor necrosis factor-α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 2003; 48:35-45.
41. Ceccato F, Roverano S, Barrionuevo A, Rillo O, Paira S: The role of anticyclic citrullinated peptide antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica. Clin Rheumatol 2006; 25:854-857.
42. Ansar Ahmed S, Penhale WJ, Talal N: Sex hormones, immune responses and autoimmune diseases: mechanisms of sex hormone action. Am J Pathol 1985; 121:531-551.
43. Cutolo M, Capellino S, Sulli A, Serioli B, Secchi ME, Villaggio B, Straub RH: Estrogens and autoimmune diseases. Ann NY Acad Sci 2006; 1089:538-547.
44. Walitt B, Pettinger M, Weinstein A, Katz J, Torner J, Wasko MC, Howard BV: Effects of postmenopausal hormone therapy on rheumatoid arthritis: The Women's Health Initiative Randomized Controlled Trials. Arthritis Rheum 2008; 59:302-310.
45. D'Elia HF, Larsen A, Mattsson LA, Walt-brand E, Kvist G, Mellstrom D, Saxne T, Ohlsson C, Nordborg E, Carlsten H: Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis. J Rheumatol 2003; 30: 1456-1463.
46. Punzi L, Bertazzolo N, Pianon M, Rizzi E, Rossini P, Todesco S: Synovial fluid levels of proinflammatory interleukins and their inter-relationships in elderly vs younger onset rheumatoid arthritis. Aging 1996; 8:277-281.
47. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G: Inflamm-aging. An evolutionary perspective on immunosenescence. Ann NY Acad Sci 2000; 908: 244-254.
48. Boren E, Gershwin ME: Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun Rev 2004; 3:401-406.
49. Kirkland JL: The biology of senescence: potential for prevention of disease. Clin Geriatr Med 2002; 18:383-405.
50. Elliott MJ, Woo P, Charles P, Long-Fox A, Woody JN, Maini RN: Suppression of fever and the acute-phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumor necrosis factor-α(cA2). Br J Rheumatol 1997; 36:589-593.
51. Marcora SM, Chester KR, Mittal G, Lemmey AB, Maddison PJ: Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis. Am J Clin Nutr 2006; 84: 1463-1472.
52. Meyer O, Labarre C, Dougados M, Goupille Ph, Cantagrel A, Dubois A, Nicaise-Roland P, Sibilia J, Combe B: Anticitrullinated pro-tein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 2003; 62:120-126.
53. Tutuncu Z, Reed G, Kremer J, Kavanaugh A: Do patients with older-onset rheumatoid arthritis receive less aggressive treatment? Ann Rheum Dis 2006; 65:1226-1229.